Cargando…

Is there any relationship between mutation in CPS1 Gene and pregnancy loss?

BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 de...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebi, Mehrdad, Yahya Vahidi Mehrjardi, Mohammad, Kalhor, Kambiz, Dehghani, Mohammadreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Knowledge E 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653490/
https://www.ncbi.nlm.nih.gov/pubmed/31435610
http://dx.doi.org/10.18502/ijrm.v17i5.4604
_version_ 1783438590950244352
author Talebi, Mehrdad
Yahya Vahidi Mehrjardi, Mohammad
Kalhor, Kambiz
Dehghani, Mohammadreza
author_facet Talebi, Mehrdad
Yahya Vahidi Mehrjardi, Mohammad
Kalhor, Kambiz
Dehghani, Mohammadreza
author_sort Talebi, Mehrdad
collection PubMed
description BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease. CASE: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 [Formula: see text] g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 [Formula: see text] mol/L; reference range, 236–410 [Formula: see text] mol/L), glutamine (2,256 [Formula: see text] mol/L; reference range, 20–107 [Formula: see text] mol/L), asparagine (126 [Formula: see text] mol/L; reference range, 30–69 [Formula: see text] mol/L), glutamic acid (356 [Formula: see text] mol/L; reference range, 14–192 [Formula: see text] mol/L), aspartic acid (123 [Formula: see text] mol/L; reference range, 0–24 [Formula: see text] mol/L), and lysine (342 [Formula: see text] mol/L; reference range, 114–269 [Formula: see text] mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G [Formula: see text] C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously. CONCLUSION: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs.
format Online
Article
Text
id pubmed-6653490
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Knowledge E
record_format MEDLINE/PubMed
spelling pubmed-66534902019-08-21 Is there any relationship between mutation in CPS1 Gene and pregnancy loss? Talebi, Mehrdad Yahya Vahidi Mehrjardi, Mohammad Kalhor, Kambiz Dehghani, Mohammadreza Int J Reprod Biomed Case Report BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease. CASE: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 [Formula: see text] g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 [Formula: see text] mol/L; reference range, 236–410 [Formula: see text] mol/L), glutamine (2,256 [Formula: see text] mol/L; reference range, 20–107 [Formula: see text] mol/L), asparagine (126 [Formula: see text] mol/L; reference range, 30–69 [Formula: see text] mol/L), glutamic acid (356 [Formula: see text] mol/L; reference range, 14–192 [Formula: see text] mol/L), aspartic acid (123 [Formula: see text] mol/L; reference range, 0–24 [Formula: see text] mol/L), and lysine (342 [Formula: see text] mol/L; reference range, 114–269 [Formula: see text] mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G [Formula: see text] C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously. CONCLUSION: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs. Knowledge E 2019-06-26 /pmc/articles/PMC6653490/ /pubmed/31435610 http://dx.doi.org/10.18502/ijrm.v17i5.4604 Text en Copyright © 2019 Mehrdad Talebi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Case Report
Talebi, Mehrdad
Yahya Vahidi Mehrjardi, Mohammad
Kalhor, Kambiz
Dehghani, Mohammadreza
Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title_full Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title_fullStr Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title_full_unstemmed Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title_short Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
title_sort is there any relationship between mutation in cps1 gene and pregnancy loss?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653490/
https://www.ncbi.nlm.nih.gov/pubmed/31435610
http://dx.doi.org/10.18502/ijrm.v17i5.4604
work_keys_str_mv AT talebimehrdad isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss
AT yahyavahidimehrjardimohammad isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss
AT kalhorkambiz isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss
AT dehghanimohammadreza isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss